Clinical Trials Logo

Filter by:
NCT ID: NCT05615571 Completed - Clinical trials for Neurodegeneration With Brain Iron Accumulation (NBIA)

Testing of NBIA Genes: Analysis of Genetic Heterogeneity and Validation of Mitochondrial Markers for Assessing Causality of Sequence Variants.

NBIA MITO
Start date: January 4, 2018
Phase:
Study type: Observational

Neurodegeneration with brain iron accumulation (NBIA) represent a group of rare neurodevelopmental diseases, genetically as well as phenotypically heterogeneous. The diagnosis is based on brain MRI. It is also based on genetic testing. However overlaps exist between the different clinical presentations and the molecular diagnosis may be misinterpreted. Two main purposes must be addressed to get a better molecular diagnosis: on one hand reaching enough exhaustivity which may be performed with a larger gene panel and next generation sequencing; on the other hand, it is now necessary to validate or infirm the deleterious consequences of variants with the help of functional studies.

NCT ID: NCT05615181 Completed - Trismus Clinical Trials

Evaluation of the French Translation of Gothenburg Trismus Questionnaire (GTQ)

TRISMUS
Start date: December 22, 2020
Phase:
Study type: Observational

A monocentric Study to evaluate the french translation of Gothenburg Trismus Questionnaire (GTQ).

NCT ID: NCT05614895 Completed - Clinical trials for Bacterial Infections

A Study to Investigate the Pharmacokinetics of RO7223280 in Critically Ill Participants With Bacterial Infections

Start date: December 3, 2022
Phase: Phase 1
Study type: Interventional

The main aim of the study is to investigate the plasma pharmacokinetics (PK) and safety of intravenous (IV) administration of a single dose of 400 milligrams (mg) or 600 mg RO7223280 in critically ill participants with bacterial infections.

NCT ID: NCT05614635 Completed - Edentulous Mouth Clinical Trials

Safety and Technical Performance of Plastalgin and Plastalgin Fast in Patients Requiring a Dental Impression

Start date: October 12, 2022
Phase:
Study type: Observational [Patient Registry]

The aim of this study is to gather clinical data related to the use of Plastalgin and Plastalgin Fast, in order to comply with the new medical device regulation. The target population for this study is the same as the intended population specified in the study device's instructions for use: children from 5 years old and adults. Collection, recording, and reporting of data will be accurate and will ensure the privacy, health, and welfare of participating patients during and after the study

NCT ID: NCT05613530 Completed - Simulation Clinical Trials

Mobile Application as a Clinical Decision Support Tool for Neonatal Resuscitation in the Delivery Room

MAXnéonat
Start date: May 19, 2021
Phase: N/A
Study type: Interventional

The need for neonatal cardiopulmonary resuscitation in the delivery room is rare with less than 1% of newborns requiring advanced resuscitation. The use of clinical decision support tools to guide practitioners on medical procedure steps is recognized by the medical community. In this randomized bi-centric controlled study, we investigate the effect of a mobile phone application on technical and non-technical performance of student trinomials managing simulated critical neonatal events

NCT ID: NCT05613517 Completed - No Eye Disorder Clinical Trials

Study of the Angle Lambda and Ocular Dominance

EPOLAF
Start date: November 25, 2022
Phase:
Study type: Observational

Anatomical ophthalmological connections and their dynamics are still debated in the scientific community. However, their considering is essential in many surgeries (strabismus, cataract, refractive...) or in clinical practice. The correlation between these biometric values would make it possible to refine the knowledge related to these landmarks and thus offer better ophthalmological management by integrating these variables into the clinical examination. The aim of the study is to analyze the correlation between the angle lambda and the ocular dominance depth in healthy individuals without ophthalmologic disorder. Then, seconds goals were defined as the study of the relation between the value of the angle lambda and the fixation disparity quantified with the Rousseau test. Relation between ocular dominance measured with the Guillon's test and the Hole-in-car test will also studied.

NCT ID: NCT05613244 Completed - Orbital Tumor Clinical Trials

Descriptive Study of a Cohort of Orbital Solitary Fibrous Tumors

TFS-ORB
Start date: January 26, 2023
Phase:
Study type: Observational

Orbital solitary fibrous tumors are rare tumors with an intermediate potential of malignancy. Orbital solitary fibrous tumors' prognostic criteria are still poorly understood. Some patients with orbital solitary fibrous tumors have been treated at the Adolphe de Rothschild Foundation Hospital. This cohort will be studied to describe the recurrence rate and to identify predictive factors of recurrence or metastasis.

NCT ID: NCT05612555 Completed - Clinical trials for Ventricular Assist Device

Low Psoas Index and Cardiac Assistance: No Excess Mortality at D28 Post Implantation

VAD
Start date: September 9, 2019
Phase:
Study type: Observational

The frailty syndrome is important to consider in perioperative cardiac assistance. One of its components is the patient's sarcopenia. This can be assessed by measuring the size of the psoas muscle. For this purpose, one of the most studied measures seems to be the measurement of the Psoas Index. This is a contouring of the psoas muscle, performed on an axial section of a CT scan, at the level of the L4 vertebra, which is then matched to the body surface. However, there is no standardization of measurements and volume acquisitions, and different image processing is also described. A radiological evaluation of the psoas could overcome this difficulty and provide a rapid and available screening tool for sarcopenia.

NCT ID: NCT05612542 Completed - Clinical trials for Antibiotic Prophylaxis

Pediatric Cardiac Surgery Comparing Short 24-hour Antibiotic Prophylaxis to Extended Antibiotic Prophylaxis

Prophylaxis
Start date: September 2, 2019
Phase:
Study type: Observational

The objective of antibiotic prophylaxis is to prevent bacterial proliferation in order to reduce the risk of postoperative infection. Numerous recent recommendations show a benefit of a reduced duration of antibiotic prophylaxis in surgery, particularly in pediatrics. The study focuses on the incidence of postoperative infection by comparing antibiotic prophylaxis with 2nd generation cephalosporin (G2G) for 48 hours to a short antibiotic prophylaxis protocol limited to 24 hours. The bacterial infections considered were those said to be care-related, according to the criteria of the French Society of Anesthesia and Intensive Care if they occurred within the 3 months postoperative interval and were not present before the surgery: - sepsis - superficial or deep surgical site infection (mediastinitis, sternitis, scar infection) - catheterization infection, - urinary tract infection or - respiratory infection such as pneumopathy acquired under mechanical ventilation The hypothesis is that reducing the duration of antibiotic prophylaxis does not expose patients to an increased risk of infection and limits exposure to antibiotics

NCT ID: NCT05610930 Completed - Clinical trials for Objective Understanding of Nutritional Label

Is a Front-of-package Label Contaning Information on Both Nutrient Profile and Ultra-processing Well Understood?

Start date: May 1, 2022
Phase: N/A
Study type: Interventional

A modified version of the Nutri-Score (Nutri-Score 2.0), containing an additional graphic mention when the product is ultra-processed, has been proposed. The investigators aim to study, in a randomised controlled trial design nested in the NutriNet-Santé cohort, the impact of this modified version on the objective understanding of foods' nutritional quality, and on the identification of UPFs as primary outcomes. They also aim to study as secondary outcomes the impact of this label on purchasing intentions and the product perceived as the healthiest.